chartexchange

VNDA
Vanda Pharmaceuticals Inc.
stockNASDAQ

At CloseNov 13, 2026 4:00:00 PM EST
4.00USD+1.266%(+0.05)823,278
Pre-marketNov 13, 2026 9:28:30 AM EST
3.94USD-0.253%(-0.01)
After-hoursNov 13, 2026 4:04:30 PM EST
4.03USD+0.750%(+0.03)
Loading…
Loading…
241.88M
Healthcare
Biotechnology
CEO
Mihael Polymeropoulos
HQ
Washington, DC, USA
Previous Close
$3.95
Beta
0.86
52-Week High
$9.94 2026-03-10
52-Week Low
$3.57 2026-11-05
SMA 50
$4.52
SMA 200
$6.04
Avg. Vol 10D
1.38M
Avg. Vol 30D
1.20M
Avg. Vol 90D
1.04M
Relative Vol
0.59
57.21M
0.3500%
1,711
VNDA Profile

vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

VNDA Performance
PeriodPriceDateChangeBeta
1W3.822026-11-06+4.71%3.336
1M4.302026-10-13-6.98%1.937
3M5.032026-08-13-20.48%1.515
6M6.432026-05-13-37.79%1.099
1Y4.342025-11-13-7.83%0.859
2Y5.462024-11-13-26.74%—
5Y17.762021-11-12-77.48%0.706
VNDA Stock Summary

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) stock price today is $4.00, and today's volume is 710,599. VNDA is up 1.266% today. The 30 day average volume is 1.20M. VNDA market cap is $241.88M with 60.47M shares outstanding.